Mindmed completes 1-for-15 reverse share split

- common shares will begin trading on a split-adjusted basis at market open on august 29, 2022 - new york , aug. 26, 2022 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (the "company" or "mindmed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that its previously announced 1-for-15 reverse share split of the company's common shares, par value $0.001, became effective after the close of markets on august 26, 2022, with trading expected to begin on a split-adjusted basis on the nasdaq and the neo exchange inc. (the "neo") at market open on august 29, 2022. the common shares will continue to trade under the symbols "mnmd" on the nasdaq and "mmed" on the neo but are assigned cusip number 60255c885 and isin number ca60255c8850 following the reverse share split.
MNMD Ratings Summary
MNMD Quant Ranking